Oncurie

Oncurie, a startup company based in Raleigh, North Carolina, was spun out of NC State University with the core mission of creating a cure for metastatic cancer. The company focuses on developing innovative radiotherapeutic agents using novel molecular radionuclide technology. This approach aims to address the significant challenge of metastatic cancer, which remains a leading cause of death due to its ability to evolve and resist conventional treatments. Oncurie's market focus is primarily on the healthcare sector, targeting advanced cancer treatment solutions.

Notable affiliated individuals include researchers and experts from NC State University who have contributed to the foundational technology. The company has garnered attention from investors interested in groundbreaking cancer therapies. Key achievements include the development of proprietary radionuclide technology that shows promise in preclinical studies. Overall, Oncurie has made a significant impact by advancing potential treatments for metastatic cancer, offering hope for more effective and targeted cancer therapies in the future.